Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
D412005-100μg
|
100μg |
10
|
$39.90
|
|
|
D412005-1mg
|
1mg |
4
|
$159.90
|
|
|
D412005-5mg
|
5mg |
1
|
$664.90
|
|
|
D412005-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,196.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Durvalumab (anti-PD-L1) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to B7-H1 / PD-L1 / CD274, >95%, high purity, Human IgG1, INHIBITOR of Programmed cell death 1 ligand 1 inhib |
|---|---|
| Synonyms | Durvalumab (anti-PD-L1) | MEDI4736 | Durvalumab | MEDI 4736 | Anti-B7-H1 / PD-L1 / CD274 Reference Antibody (durvalumab) | Recombinant Durvalumab Antibody | B7 H antibody | B7 H1 antibody | B7 homolog 1 antibody | B7-H1 antibody | B7H antibody | B7H1 anti |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | B7-H1 / PD-L1 / CD274 |
| Application | ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Recombinant, Validated |
| Action Type | INHIBITOR |
| Mechanism of action | INHIBITOR of Programmed cell death 1 ligand 1 inhibitor |
| Product Description |
Durvalumab is an humanized anti-PD-L1 monoclonal antibody, completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively. |
| Antibody Type | Primary antibody |
|---|---|
| Clonality | Recombinant |
| Isotype | Human IgG1 |
| Light Chain Type | kappa |
| SDS-PAGE | 26.5 kDa (Light Chain) & 52.2 kDa (Heavy Chain), under reducing conditions; 180.0 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% |
| Source | CHO supernatant |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 1428935-60-7 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Durvalumab (anti-PD-L1) (D412005) - Flow Cytometry
Flow Cytometry analysis of PBMC cells labelling PD-L1 (red) with Durvalumab (anti-PD-L1) (D412005) . Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Durvalumab (anti-PD-L1) (D412005) - SEC
The purity of Durvalumab (anti-PD-L1) (D412005) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Apr 08, 2024 | D412005 | |
| Certificate of Analysis | Apr 08, 2024 | D412005 | |
| Certificate of Analysis | Apr 08, 2024 | D412005 |
Starting at $109.90
Starting at $109.90
Starting at $109.90
Starting at $109.90
Starting at $34.90
Starting at $79.90
Starting at $79.90
Starting at $109.90
Starting at $56.90
Starting at $89.90
Starting at $69.90
Starting at $16.90
Starting at $49.90
Starting at $109.90
Starting at $66.90